Sabine Mueller, Md, Phd
Clinical trials sponsored by Sabine Mueller, Md, Phd, explained in plain language.
-
New hope for kids with rare brain cancer: drug combo trial launches
Disease control Not yet recruitingThis study tests two new drug combinations for children, teens, and young adults whose atypical teratoid rhabdoid tumor (ATRT) has come back or is growing. About 29 participants will receive either gemcitabine plus paxalisib or another experimental therapy. The goal is to see if …
Phase: PHASE2 • Sponsor: Sabine Mueller, MD, PhD • Aim: Disease control
Last updated May 26, 2026 11:59 UTC
-
New hope for kids with aggressive brain cancer: thyroid hormone combo shows promise
Disease control Not yet recruitingThis study tests a thyroid hormone (liothyronine) combined with standard chemotherapy drugs for children and young adults whose medulloblastoma has returned or worsened. The goal is to see if the combination is safe and can control the disease. About 69 participants will be enrol…
Phase: PHASE1, PHASE2 • Sponsor: Sabine Mueller, MD, PhD • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New hope for young brain tumor patients: experimental drug combo enters trials
Disease control Not yet recruitingThis study tests whether adding an experimental drug (ADI-PEG 20) to standard radiation and chemotherapy can help children, teens, and young adults with newly diagnosed high-grade glioma. About 97 participants will receive the drug combination to see if it is safe and delays tumo…
Phase: PHASE1, PHASE2 • Sponsor: Sabine Mueller, MD, PhD • Aim: Disease control
Last updated May 18, 2026 12:13 UTC